The effect of turmeric on depression and anxiety

Study the effectiveness of curcumin on depression in patients with depression and anxiety

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180404039187N10

Enrollment

100

Registered

2023-07-22

Start date

2023-06-20

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Depression. Condition 2: Anxiety. Major depressive disorder, single episode, moderate Generalized anxiety disorder

Interventions

Intervention 1: Intervention group: Receive 500 mg curcumin capsules for 8 weeks. Intervention 2: Control group: placebo recipient.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Being at least 18 years old and at most 65 years old Suffering from depression and anxiety

Exclusion criteria

Exclusion criteria: Allergy to curcumin pregnancy breastfeeding Consumption of curcumin products Age less than 18 and more than 65 years Having a mental illness other than depression and anxiety

Design outcomes

Primary

Measure	Time frame
Symptoms of depression and anxiety. Timepoint: At the beginning of the study and week 4 and week 8. Method of measurement: Hamilton questionnaire for depression and Beck questionnaire for anxiety.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElnaz shaseb

Tabriz University of Medical Sciences

Elnaz_shaseb_64@yahoo.com+98 41 3335 5921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026